Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 165 publications
Cyclin-Dependent Kinase 5 Contributes to Bruton's Tyrosine Kinase Inhibitor Resistance via the IRE1α/XBP1 Axis in Mantle Cell Lymphoma.
Journal: Research square
Published: May 18, 2026
Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Versus-Host Disease and Nonrelapse Mortality After Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: May 01, 2026
CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.
Journal: American journal of clinical pathology
Published: March 14, 2026
Real-world treatment patterns and characteristics of patients with diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of US commercial and Medicare claims (2017-2024).
Journal: Leukemia & lymphoma
Published: January 19, 2026
Cyclin-Dependent Kinase-9 and Oxidative Phosphorylation Inhibition Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma.
Journal: Cancer research communications
Published: December 30, 2025
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma.
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma.
Journal: Leukemia & lymphoma
Published: October 31, 2025
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025.
Journal: Cancer
Published: September 24, 2025
Impact on Student Confidence and Acceptability of a Virtual Reality (VR) Exoskeleton for Teaching Postpartum Uterine Balloon Insertion.
Journal: Medical science educator
Published: June 18, 2025
Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma.
Journal: Leukemia & lymphoma
Published: June 09, 2025
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial.
Journal: Annals of hematology
Published: May 16, 2025
Last Updated: 09/26/2026